Literature DB >> 26750127

Developments in Varicella Zoster Virus Vasculopathy.

Maria A Nagel1, Don Gilden2,3.   

Abstract

Varicella zoster virus (VZV) is a highly neurotropic human herpesvirus. Primary infection usually causes varicella (chicken pox), after which virus becomes latent in ganglionic neurons along the entire neuraxis. VZV reactivation results in zoster (shingles) which is frequently complicated by chronic pain (postherpetic neuralgia). VZV reactivation also causes meningoencephalitis, myelitis, ocular disorders, and vasculopathy, all of which can occur in the absence of rash. This review focuses on the association of VZV and stroke, and on the widening spectrum of disorders produced by VZV vasculopathy in immunocompetent and immunocompromised individuals, including recipients of varicella vaccine. Aside from ischemic stroke, VZV infection of cerebral arteries may lead to development of intracerebral aneurysms, with or without hemorrhage. Moreover, recent clinical-virological case reports and retrospective pathological-virological analyses of temporal arteries positive or negative for giant cell arteritis (GCA) indicate that extracranial VZV vasculopathy triggers the immunopathology of GCA. While many patients with GCA improve after corticosteroid treatment, prolonged corticosteroid use may potentiate VZV infection, leading to fatal vasculopathy in the brain and other organs.

Entities:  

Keywords:  Aneurysm; Giant cell arteritis; Stroke; Varicella zoster virus vasculopathy; Zoster

Mesh:

Year:  2016        PMID: 26750127      PMCID: PMC5489063          DOI: 10.1007/s11910-015-0614-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  43 in total

1.  ZOSTER MENINGOENCEPHALITIS IN A STEROID-TREATED PATIENT.

Authors:  J TAKO; J P RADO
Journal:  Arch Neurol       Date:  1965-06

2.  Evidence for vascular spread of varicella zoster-associated vasculopathy.

Authors:  Takeshi Saraya; Chie Shimura; Hiroo Wada; Masahiro Aoshima; Hajime Goto
Journal:  Ann Intern Med       Date:  2006-04-04       Impact factor: 25.391

3.  Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency.

Authors:  Angela Sabry; Pia J Hauk; Huie Jing; Helen C Su; Nicholas V Stence; David M Mirsky; Maria A Nagel; Jordan K Abbott; Leonard L Dragone; Jennifer Armstrong-Wells; Donna J Curtis; Randall Cohrs; D Scott Schmid; Don Gilden; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2014-01-11       Impact factor: 10.793

4.  Postlicensure safety surveillance for varicella vaccine.

Authors:  R P Wise; M E Salive; M M Braun; G T Mootrey; J F Seward; L G Rider; P R Krause
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

5.  High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy.

Authors:  Esteban Cheng-Ching; Stephen Jones; Ferdinand K Hui; Shumei Man; Don Gilden; Adarsh Bhimraj; Ken Uchino
Journal:  J Neurol Sci       Date:  2015-02-16       Impact factor: 3.181

6.  A case of intracranial saccular aneurysm after primary varicella zoster virus infection.

Authors:  Masao Kawatani; Akio Nakai; Takashi Okuno; Hirokazu Tsukahara; Yusei Ohshima; Mitsufumi Mayumi
Journal:  Brain Dev       Date:  2011-03-05       Impact factor: 1.961

7.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

8.  [Cerebral vasculitis with aneurysms caused by varicella-zoster virus infection during AIDS: a new clinicoangiographical syndrome].

Authors:  T de Broucker; D Verollet; Y Schoindre; C Henry; L Martinez-Almoyna; J Tourret; V Joly; P Yeni
Journal:  Rev Neurol (Paris)       Date:  2008-01-25       Impact factor: 2.607

Review 9.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

10.  Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Authors:  Maria A Nagel; Teresa White; Nelly Khmeleva; April Rempel; Philip J Boyer; Jeffrey L Bennett; Andrea Haller; Kelly Lear-Kaul; Balasurbramaniyam Kandasmy; Malena Amato; Edward Wood; Vikram Durairaj; Franz Fogt; Madhura A Tamhankar; Hans E Grossniklaus; Robert J Poppiti; Brian Bockelman; Kathy Keyvani; Lea Pollak; Sonia Mendlovic; Mary Fowkes; Charles G Eberhart; Mathias Buttmann; Klaus V Toyka; Tobias Meyer-ter-Vehn; Vigdis Petursdottir; Don Gilden
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

View more
  15 in total

1.  Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases.

Authors:  Leonard H Calabrese; Fenglong Xie; Huifeng Yun; Kevin L Winthrop; John W Baddley; Cassandra Calabrese; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 2.  [Skin diseases due to systemic vasculitides and vasculopathies].

Authors:  S Volc; J C Maier; M Röcken
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 3.  Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Authors:  Rochella A Ostrowski; Sheela Metgud; Rodney Tehrani; Walter M Jay
Journal:  Neuroophthalmology       Date:  2019-07-02

4.  Meningitis/meningoencephalitis caused by varicella zoster virus reactivation: a retrospective single-center case series study.

Authors:  Yongxing Yan; Yanrong Yuan; Jun Wang; Yan Zhang; Huili Liu; Zuyong Zhang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

5.  Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone.

Authors:  Markus Kraemer; Daniel Strunk; Jana Becker; Roland Veltkamp; Peter Berlit
Journal:  Neurol Res Pract       Date:  2022-05-16

Review 6.  Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy-case report and review of literature.

Authors:  Shishir Kumar; Shibu V Pillai
Journal:  Childs Nerv Syst       Date:  2019-02-25       Impact factor: 1.532

7.  Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS.

Authors:  Jake A Deviley; Darby Oldenburg; Laurence C Berg; William A Agger
Journal:  J Neurovirol       Date:  2018-11-26       Impact factor: 3.739

Review 8.  Variations in herpes zoster manifestation.

Authors:  Uwe Wollina
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

9.  Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study.

Authors:  Te-Yu Lin; Fu-Chi Yang; Cheng-Li Lin; Chia-Hung Kao; Hsin-Yi Lo; Tse-Yen Yang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  A Susceptible Mouse Model for Zika Virus Infection.

Authors:  Stuart D Dowall; Victoria A Graham; Emma Rayner; Barry Atkinson; Graham Hall; Robert J Watson; Andrew Bosworth; Laura C Bonney; Samantha Kitchen; Roger Hewson
Journal:  PLoS Negl Trop Dis       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.